U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H20Cl2N2O
Molecular Weight 327.249
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of BRASOFENSINE

SMILES

CO\N=C\[C@H]1[C@H]2CC[C@@H](C[C@@H]1C3=CC=C(Cl)C(Cl)=C3)N2C

InChI

InChIKey=NRLIFEGHTNUYFL-QJDHNRDASA-N
InChI=1S/C16H20Cl2N2O/c1-20-11-4-6-16(20)13(9-19-21-2)12(8-11)10-3-5-14(17)15(18)7-10/h3,5,7,9,11-13,16H,4,6,8H2,1-2H3/b19-9+/t11-,12+,13+,16+/m0/s1

HIDE SMILES / InChI

Molecular Formula C16H20Cl2N2O
Molecular Weight 327.249
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 1
Optical Activity UNSPECIFIED

NeuroSearch was developing brasofensine (or NS 2214), an oral dopamine reuptake inhibitor for the treatment of Parkinson's disease. Brasofensine successfully passed phase II clinical trial in patients with Parkinson's disease, The drug was safe and well tolerated. However, NeuroSearch discontinued the development of the drug because of the cis-anti isomerization of the 2α-methyloxime group of brasofensine in favor of NS 2230.

Approval Year

PubMed

PubMed

TitleDatePubMed
Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa.
2002 Feb
Drugs in development for Parkinson's disease.
2004 Jul
Disposition and metabolism of [14C]brasofensine in rats, monkeys, and humans.
2008 Jan
Patents

Sample Use Guides

a single oral dose of brasofensine 0.5, 1, 2, or 4 mg, which was coadministered with the patient's usual dose of levodopa/carbidopav
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:20:46 GMT 2023
Edited
by admin
on Sat Dec 16 17:20:46 GMT 2023
Record UNII
1YP2S94RVH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BRASOFENSINE
INN   WHO-DD  
INN  
Official Name English
3.BETA.-(3,4-DICHLOROPHENYL)-1.ALPHA.H,5.ALPHA.H-TROPANE-2.ALPHA.-CARBOXALDEHYDE (E)-(O-METHYLOXIME)
Common Name English
brasofensine [INN]
Common Name English
Brasofensine [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C38149
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID00905102
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
EVMPD
SUB05881MIG
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104184
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
SMS_ID
100000088658
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
MESH
C415103
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
CAS
171655-91-7
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
PUBCHEM
9614919
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
NCI_THESAURUS
C76391
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
INN
7530
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
WIKIPEDIA
BRASOFENSINE
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
DRUG BANK
DB04857
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
FDA UNII
1YP2S94RVH
Created by admin on Sat Dec 16 17:20:47 GMT 2023 , Edited by admin on Sat Dec 16 17:20:47 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Tmax PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC